Laura is the vice president of content for The American Journal of Managed Care® (AJMC®) and all its brands, including Population Health, Equity & Outcomes; Evidence-Based Oncology™; and The Center for Biosimilars®. She has been working on AJMC since 2014 and has been with AJMC’s parent company, MJH Life Sciences®, since 2011.
She has an MA in business and economic reporting from New York University. You can connect with Laura on LinkedIn or Twitter.
Women, Uninsured More Likely to Use Strategies to Reduce Prescription Drug Costs
April 19th 2019The percentage of US adults who used strategies to reduce prescription drug costs, such as skipping medication doses, asking the doctor for a lower-cost medication, and using alternative therapies, was stable from 2015 to 2017 and was down from 2013 to 2015.
ctDNA Can Detect MRD and Early Cancer Recurrence in Colorectal Cancer
April 19th 2019Circulating tumor DNA (ctDNA) can be analyzed in patients with cancer to detect minimal residual disease (MRD). Two abstracts, presented at the American Association for Cancer Research Annual Meeting 2019, evaluated ctDNA analysis and ways of tracking MRD.
Dim Light at Night May Help Spread Breast Cancer to Bones
April 18th 2019When breast cancer spreads, it often goes to the bones, and new research has found that exposure to dim light at night may contribute to this spread. Results from the animal study were presented at ENDO 2019, the annual meeting of the Endocrine Society.
The Race Against Antibiotic Resistance: Addressing a Growing Public Health Crisis
April 12th 2019When antibiotics were discovered, they were considered a miracle. Decades of overuse have created a current public health crisis with a growing number of antibiotic-resistant bacteria. However, not all hope is lost in the fight against antibiotic resistance. There are programs in place to promote judicious use of antibiotics and policies and funding to help incentivize development of new antibiotics.
New Estimate Shows Prevalence of MS Has Increased Steadily, Is at Highest Level
April 9th 2019In the past 5 decades, there has been a steady rise in the prevalence of multiple sclerosis (MS), according to estimates using a validated algorithm across 5 large US administrative health claims data sets. The research was published in Neurology.
NGS Identifies Survival, Treatment Outcomes for Patients With CRC Genetic Mutations
April 7th 2019Genetic alternations in colorectal cancer (CRC) are linked to different survival and treatment outcomes, according to a study that used next-generation sequencing (NGS) of tumor DNA. The study was published in Journal of Clinical Oncology.
Blue Cross NC and Duke Health Partner on New Health Insurance Company
April 5th 2019Rising healthcare costs and challenges with access to care have given rise to innovations in healthcare and new partnerships. Now, Blue Cross and Blue Shield of North Carolina (Blue Cross NC) is partnering with Duke University Health System (Duke Health) to create a new health insurance company to meet the needs of seniors.
Female Reproductive Factors Do Not Modify MS Prognosis
April 4th 2019Women with multiple sclerosis (MS) who give birth do not face an increased risk of relapses postpartum. New research being presented in May at the American Academy of Neurology annual meeting found the time right after pregnancy is one of the periods in which MS symptoms may not flare back up.
Value-Based Care Is Changing Cancer Treatment Decisions as Drug Costs Continue to Rise
March 31st 2019As novel therapies drive up the cost of drugs, it is becoming increasingly difficult for community oncologists to keep costs below value-based care program targets, according to a new survey from Integra Connect.
Racially Diverse Cell Lines Needed for Precision Medicine to Reach Underrepresented Populations
March 27th 2019A lack of diversity in cell lines used for laboratory studies means underrepresented populations and minorities might not benefit from precision medicines as quickly as people from European ancestry.
DOJ Reverses Course, Sides With Judge Striking Down ACA
March 26th 2019The Department of Justice now backs the ruling from a district court judge in Texas that said the entire Affordable Care Act (ACA) is invalidated without the individual mandate, which was removed when Congress reduced the penalty to $0.
Different Vantage Points, but Similar Goals of High-Value Care, Patient Satisfaction
March 22nd 2019A diverse panel of representatives from different practice models provided insights into what has worked for them and what has not in trying to improve cancer care. The discussion took place in Washington, DC, at the Association of Community Cancer Centers
Creating a New Way to Implement VBID Principles in Exchange Health Plans
March 19th 2019Value-based insurance design (VBID) aligns patient cost sharing with the value of clinical services, so that patients pay less for high-value services and more for unnecessary, low-value services. While there has been increased interest in VBID, with CMS expanding the VBID demonstration in Medicare Advantage to all 50 states, the situation on the state exchanges is different: The plan has to be cost neutral, so in order to remove cost sharing for high-value services, cost sharing has to increase for other, low-value services.
The Necessity of Addressing Cost Burden on Patients
March 17th 2019While the high price of drugs is an issue, what is really important is the actual cost patients are faced with at the pharmacy counter, said Ted Okon, executive director of the Community Oncology Alliance, and Daniel Klein, president and executive director of the Patient Access Network Foundation, at the University of Michigan Center for Value-Based Insurance Design (V-BID), V-BID Summit.
A Compressed Flu Vaccine Schedule Could Benefit Older Adults
March 15th 2019A compressed vaccine schedule for older adults could help increase uptake and decrease the impact of the influenza vaccine’s waning effectiveness as months go by, but such a schedule would not be beneficial if flu season peaks early or if a compressed schedule results in a decrease in vaccine uptake.